วันที่ 25 กุมภาพันธ์ 2558 February 23, 2018 Subject: Management’s Discussion and Analysis for the year ended December 31, 2017 Attention: Director and Manager The Stock Exchange of Thailand LDC
persons, which Section 29 in conjunction with Section 33, Section 34, Section 41, Section 43, Section 44 and Section 64 of the Constitution of the Kingdom of Thailand which legislatively permit so by the
persons, which Section 29 in conjunction with Section 33, Section 34, Section 41, Section 43, Section 44 and Section 64 of the Constitution of the Kingdom of Thailand which legislatively permit so by the
translation is strictly for reference. The SEC, Thailand cannot undertake any responsibility for its accuracy, nor be held liable for any loss of damages arising from or related to its use
for reference. The SEC, Thailand cannot undertake any responsibility for its accuracy, nor be held liable for any loss of damages arising from or related to its use. ---------------------- The Office of
for reference. The SEC, Thailand cannot undertake any responsibility for its accuracy, nor be held liable for any loss of damages arising from or related to its use. ---------------------- The Office of
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the second quarter of 2019 at the end of 30th June 2019 as follows
Stock Exchange of Thailand Pursuant to JAS Asset Public Company Limited (the “Company”) Meeting Resolution No. 4/2018 on 8 August 2018, the resolution to certify the Company’s financial statements and
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at the end of 30th September 2018 as
/4 Ref: J61/011 12 November 2018 Subject: Management Discussion and Analysis, 3rd Quarter Ending 30 September 2018 To: President The Stock Exchange of Thailand Regarding to JAS Asset Public Company